Since its introduction to the market in 2012, Unyvero has been brought into numerous hospital laboratories and intensive care units throughout Europe. Leading clinical experts have tested the system and now appreciate the advantages of the Unyvero Solution in everyday clinical use.
Curetis to Publish its 2017 Annual Results on April 30, 2018
Curetis Launches CE-IVD Marked Unyvero Urinary Tract Infection (UTI) Cartridge at ECCMID 2018
Deutsche Biotechnologietage 2018 - Berlin, Germany - April 18 to 19, 2018
28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Madrid, Spain - 21 to 24 April, 2018